Fresenius Teams with HCACO - Analyst Blog
April 09 2013 - 9:10AM
Zacks
World's largest dialysis company
Fresenius Medical Care (FMS) revealed an agreement
with Heritage California ACO (“HCACO”), an Accountable Care
Organization affiliated to Heritage Provider Network, to provide
composite health management for HCACO enrollees suffering from End
Stage Renal Disease. The understanding is along the lines of a
population health program under which Fresenius Medical Care will
strive to enhance outcomes and curtail cost of care.
Dialysis sustains life by removing
surplus fluids and cleansing waste material from the blood stream
when a patient’s kidneys stop functioning.
The population health initiative is
tailored after the 5-year model project conducted by Fresenius
Health Partners (subsidiary of Fresenius Medical Care) on Medicare
enrollees supported by dialysis. The project, completed in December
2010, was conducted with Centers for Medicare & Medicaid
Services (“CMS”). Benefits from the project include lower health
care costs, reduced mortality and a fall in hospitalizations.
Heritage California ACO has an
affiliation with the Heritage Provider Network group of
entities. Heritage Provider Network provides health care to
more than 700,000 persons. It operates in eight counties of
California, New York and Arizona.
Fresenius is the largest provider
of products and services for patients undergoing dialysis
treatment. The company’s principal competitor in the U.S. is
DaVita Inc. (DVA), which provides dialysis
services for patients suffering from chronic kidney failure or end
stage renal disease. Fresenius also competes with Baxter
International (BAX) in certain niches such as peritoneal
dialysis products.
The company continues to register
strong operating results in the North American as well as overseas
markets. The integration of acquisitions is also expected to be
accretive to Fresenius’ earnings in the near term. However, the
contagion of lingering economic problems in Europe remains a matter
of concern.
The stock carries a Zacks Rank #3
(Hold). Cyberonics Inc. (CYBX) carries a Zacks
Rank #1 (Strong Buy) and is expected to do well.
BAXTER INTL (BAX): Free Stock Analysis Report
CYBERONICS INC (CYBX): Free Stock Analysis Report
DAVITA INC (DVA): Free Stock Analysis Report
FRESENIUS MED (FMS): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2024 to Jul 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Jul 2023 to Jul 2024